Chicago, IL, United States of America

Catherine A O'Brian

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Houston, TX (US) (2014)
  • Chicago, IL (US) (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Catherine A O'Brian

Introduction

Catherine A O'Brian is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of peptide antigens, holding 2 patents that showcase her innovative approach to immunogenicity.

Latest Patents

One of her latest patents is focused on the controlled modulation of amino acid side chain length of peptide antigens. This invention provides a method for creating peptide antigens that include epitopes with modifications to the amino acid side chain. By extending or shortening the side chain using CH3/CH2 groups, and employing computer-assisted modeling of tumor antigens bound in the MHC-I-groove, the immunogenicity of these antigens can be enhanced. This method allows for minimal alteration of the adjacent tertiary structure, thereby reducing the risk of cross-reactivity. The invention also outlines methods for therapeutic or prophylactic treatment of various conditions through the administration of these antigens.

Career Highlights

Catherine has worked with esteemed organizations such as the University of Texas System and the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. Her work in these institutions has furthered her research and development in the field of immunology.

Collaborations

Throughout her career, Catherine has collaborated with notable colleagues, including Constantin G Ioannides and Martin L Campbell. These partnerships have contributed to her innovative research and the advancement of her inventions.

Conclusion

Catherine A O'Brian's contributions to the field of peptide antigens demonstrate her commitment to innovation and research. Her patents reflect her expertise and the potential impact of her work on therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…